US5766573A
(en)
|
1988-12-06 |
1998-06-16 |
Riker Laboratories, Inc. |
Medicinal aerosol formulations
|
DE4003270A1
(de)
|
1990-02-03 |
1991-08-08 |
Boehringer Ingelheim Kg |
Neue treibgase und ihre verwendung in arzneimittelzubereitungen
|
EP0526481B1
(en)
*
|
1990-03-23 |
1995-04-26 |
Minnesota Mining And Manufacturing Company |
The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
|
WO1992000107A1
(en)
*
|
1990-06-28 |
1992-01-09 |
Glaxo Inc. |
Aerosol drug formulations
|
US5126123A
(en)
*
|
1990-06-28 |
1992-06-30 |
Glaxo, Inc. |
Aerosol drug formulations
|
MX9203481A
(es)
|
1990-10-18 |
1992-07-01 |
Minnesota Mining & Mfg |
Formulaciones.
|
JP2769925B2
(ja)
*
|
1990-10-18 |
1998-06-25 |
ミネソタ マイニング アンド マニュファクチャリング カンパニー |
ベクロメタゾン17,21ジプロピオネートを含んで成るエアロゾル製剤
|
GB9024366D0
(en)
*
|
1990-11-09 |
1991-01-02 |
Glaxo Group Ltd |
Medicaments
|
GB9103824D0
(en)
*
|
1991-02-23 |
1991-04-10 |
Fisons Ag |
Formulation
|
DE69231994T3
(de)
*
|
1991-06-10 |
2010-01-21 |
Schering Corp. |
Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
|
ATE339952T1
(de)
|
1991-06-10 |
2006-10-15 |
Schering Corp |
Fluorchlorkohlenwasserstofffreie aerosolformulierungen
|
NZ244439A
(en)
|
1991-09-25 |
1994-01-26 |
Fisons Plc |
Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
|
US6123924A
(en)
*
|
1991-09-25 |
2000-09-26 |
Fisons Plc |
Pressurized aerosol inhalation compositions
|
US5658549A
(en)
*
|
1991-12-12 |
1997-08-19 |
Glaxo Group Limited |
Aerosol formulations containing propellant 134a and fluticasone propionate
|
US5916540A
(en)
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
US5744123A
(en)
*
|
1991-12-12 |
1998-04-28 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicaments
|
IL104068A
(en)
*
|
1991-12-12 |
1998-10-30 |
Glaxo Group Ltd |
Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
|
US5683676A
(en)
*
|
1991-12-12 |
1997-11-04 |
Glaxo Group Limited |
Canister containing aerosol formulations containing P134a and particulate medicaments
|
NZ246046A
(en)
*
|
1991-12-12 |
1995-12-21 |
Glaxo Group Ltd |
Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
|
DK0616524T3
(da)
|
1991-12-12 |
1999-06-21 |
Glaxo Group Ltd |
Lægemidler
|
US5736124A
(en)
*
|
1991-12-12 |
1998-04-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and particulate medicament
|
US5674471A
(en)
*
|
1991-12-12 |
1997-10-07 |
Glaxo Group Limited |
Aerosol formulations containing P134a and salbutamol
|
GB9202522D0
(en)
*
|
1992-02-06 |
1992-03-25 |
Glaxo Group Ltd |
Medicaments
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US5376359A
(en)
*
|
1992-07-07 |
1994-12-27 |
Glaxo, Inc. |
Method of stabilizing aerosol formulations
|
ES2064244B1
(es)
*
|
1992-12-02 |
1995-09-01 |
Fisons Plc |
Composiciones de aerosol presurizadas.
|
ATE144151T1
(de)
*
|
1993-01-19 |
1996-11-15 |
Hoechst Ag |
Flüssiggasformulierung zur vitalitätsprüfung von zähnen
|
FR2701859B1
(fr)
*
|
1993-02-23 |
1995-04-28 |
Lenglen Jean Luc |
Procédé pour mélanger un gaz avec au moins un liquide.
|
DE4323636A1
(de)
*
|
1993-07-15 |
1995-01-19 |
Hoechst Ag |
Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
ATE233544T1
(de)
*
|
1993-12-02 |
2003-03-15 |
Abbott Lab |
Aerosole als darreichungsform mit cfc-freiem treibmittel
|
GB9419536D0
(en)
*
|
1994-09-28 |
1994-11-16 |
Glaxo Inc |
Medicaments
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
GB9507768D0
(en)
|
1995-04-13 |
1995-05-31 |
Glaxo Group Ltd |
Method of apparatus
|
US5635161A
(en)
*
|
1995-06-07 |
1997-06-03 |
Abbott Laboratories |
Aerosol drug formulations containing vegetable oils
|
GB9515182D0
(en)
*
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
GB9526392D0
(en)
|
1995-12-22 |
1996-02-21 |
Glaxo Group Ltd |
Medicaments
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
GB9612297D0
(en)
*
|
1996-06-11 |
1996-08-14 |
Minnesota Mining & Mfg |
Medicinal aerosol formulations
|
GB9616237D0
(en)
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
US6193954B1
(en)
|
1997-03-21 |
2001-02-27 |
Abbott Laboratories |
Formulations for pulmonary delivery of dopamine agonists
|
US6120752A
(en)
*
|
1997-05-21 |
2000-09-19 |
3M Innovative Properties Company |
Medicinal aerosol products containing formulations of ciclesonide and related steroids
|
US20010031244A1
(en)
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
US6433040B1
(en)
|
1997-09-29 |
2002-08-13 |
Inhale Therapeutic Systems, Inc. |
Stabilized bioactive preparations and methods of use
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
GB9805938D0
(en)
|
1998-03-19 |
1998-05-13 |
Glaxo Group Ltd |
Valve for aerosol container
|
US6264923B1
(en)
|
1998-05-13 |
2001-07-24 |
3M Innovative Properties Company |
Medicinal aerosol formulation of ciclesonide and related compounds
|
US6451285B2
(en)
*
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
DZ2947A1
(fr)
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
US6290930B1
(en)
|
1998-12-18 |
2001-09-18 |
Baker Norton Pharmaceuticals, Inc. |
Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
CN1213732C
(zh)
*
|
2000-05-22 |
2005-08-10 |
奇斯药制品公司 |
用于加压计量吸入器的稳定药用溶液制剂
|
US6451287B1
(en)
|
2000-05-26 |
2002-09-17 |
Smithkline Beecham Corporation |
Fluorinated copolymer surfactants and use thereof in aerosol compositions
|
GB0016876D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Novel formulation
|
AU2001290075A1
(en)
|
2000-09-22 |
2002-04-02 |
Glaxo Group Limited |
Novel alkanoic acid derivatives
|
KR100881258B1
(ko)
|
2000-12-22 |
2009-02-05 |
글락소 그룹 리미티드 |
살메테롤 지나포에이트를 위한 정량식 흡입기
|
US7905230B2
(en)
|
2001-05-09 |
2011-03-15 |
Novartis Ag |
Metered dose inhaler with lockout
|
ATE267591T1
(de)
|
2001-07-02 |
2004-06-15 |
Chiesi Farma Spa |
Optimierte tobramycin-formulierung zur aerosolbildung
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
DE60222591T2
(de)
|
2001-08-03 |
2008-06-19 |
Glaxo Group Ltd., Greenford |
Oberflächenaktive Verbindungen und ihre Anwendungen
|
GB0125127D0
(en)
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Compounds
|
GB0128148D0
(en)
|
2001-11-23 |
2002-01-16 |
Innovata Biomed Ltd |
Assembly
|
TWI324518B
(en)
|
2001-12-19 |
2010-05-11 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
EP1474376A1
(en)
|
2002-02-13 |
2004-11-10 |
Glaxo Group Limited |
Carboxylic acid compounds for use as surfactants
|
GB0205327D0
(en)
|
2002-03-06 |
2002-04-17 |
Glaxo Group Ltd |
compounds
|
WO2004110460A1
(en)
|
2003-06-13 |
2004-12-23 |
Altana Pharma Ag |
Formoterol and ciclesonide combination
|
US8198354B2
(en)
|
2003-08-11 |
2012-06-12 |
Glaxo Group Limited |
Pharmaceutical metered dose inhaler and methods relating thereto
|
JP5053635B2
(ja)
|
2003-08-29 |
2012-10-17 |
グラクソ グループ リミテッド |
医療用定量噴霧式吸入器及びそれに関連する方法
|
ES2452691T5
(es)
|
2003-09-16 |
2022-09-14 |
Covis Pharma Gmbh |
Uso de ciclesonida para el tratamiento de enfermedades respiratorias
|
EP1595531A1
(en)
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
WO2005102429A1
(en)
|
2004-04-21 |
2005-11-03 |
Innovata Biomed Limited |
Inhaler
|
AU2006287934B2
(en)
|
2005-05-18 |
2012-12-13 |
Nektar Therapeutics |
Valves, devices, and methods for endobronchial therapy
|
JP2009510077A
(ja)
|
2005-09-29 |
2009-03-12 |
ネクター セラピューティックス |
抗生物質製剤、単位用量、キットおよび方法
|
GB0614621D0
(en)
|
2006-07-24 |
2006-08-30 |
3M Innovative Properties Co |
Metered dose dispensers
|
GB0620700D0
(en)
|
2006-10-19 |
2006-11-29 |
3M Innovative Properties Co |
Metered dose valves and dispensers
|
GB0621707D0
(en)
|
2006-10-31 |
2006-12-13 |
Univ London Pharmacy |
Formulations for delivery via pressurised metered dose inhalers
|
DK2120875T3
(en)
|
2007-02-11 |
2018-10-22 |
Map Pharmaceuticals Inc |
METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
|
GB0712454D0
(en)
|
2007-06-27 |
2007-08-08 |
Generics Uk Ltd |
Pharmaceutical compositions
|
EP2341942A1
(en)
|
2008-09-19 |
2011-07-13 |
Nektar Therapeutics |
Polymer conjugates of therapeutic peptides
|
JP2012514586A
(ja)
|
2009-01-05 |
2012-06-28 |
フラウンホーファーゲゼルシャフト ツール フォルデルング デル アンゲヴァンテン フォルシユング エー.フアー. |
Il−21およびil−21変異体に基づく抗体欠乏性疾患を治療するための手段および方法
|
AR079451A1
(es)
|
2009-12-18 |
2012-01-25 |
Nycomed Gmbh |
Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
|
WO2011150944A1
(en)
|
2010-06-04 |
2011-12-08 |
Trifoilium Aps |
Trefoil factors (tff) for the treatment of chronic pulmonary diseases
|
SG188401A1
(en)
|
2010-09-09 |
2013-04-30 |
Trifoilium Aps |
Airway administration of angiogenesis inhibitors
|
GB201108039D0
(en)
|
2011-05-13 |
2011-06-29 |
Mexichem Amanco Holding Sa |
Compositions
|
WO2012171903A1
(en)
|
2011-06-15 |
2012-12-20 |
Nycomed Gmbh |
Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
|
CA2837248A1
(en)
|
2011-06-17 |
2012-12-20 |
Takeda Gmbh |
Novel phthalazinone -pyrrolopyrimidinecarboxamide derivatives
|
GB201117619D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201117621D0
(en)
|
2011-10-12 |
2011-11-23 |
Mexichem Amanco Holding Sa |
Compositions
|
GB201118188D0
(en)
|
2011-10-21 |
2011-12-07 |
3M Innovative Properties Co |
Manufacture of medicinal aerosol canisters
|
GB201210580D0
(en)
|
2012-06-14 |
2012-08-01 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201221063D0
(en)
|
2012-11-23 |
2013-01-09 |
3M Innovative Properties Co |
Metered dose dispensing valve
|
GB201306984D0
(en)
*
|
2013-04-17 |
2013-05-29 |
Mexichem Amanco Holding Sa |
Composition
|
WO2016018892A1
(en)
|
2014-07-29 |
2016-02-04 |
3M Innovative Properties Company |
Method of preparing a pharmaceutical composition
|
ES2796177T3
(es)
|
2015-12-04 |
2020-11-26 |
Mexichem Fluor Sa De Cv |
Composición farmacéutica
|
CA3037080C
(en)
|
2016-09-19 |
2021-05-18 |
Mexichem Fluor S.A. De C.V. |
Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
|
UA123919C2
(uk)
|
2016-09-19 |
2021-06-23 |
Мехікем Флуор С.А. Де С.В. |
Фармацевтична композиція
|
CA3037107C
(en)
|
2016-09-19 |
2021-05-18 |
Mexichem Fluor S.A. De C.V. |
Stable pharmaceutical compositions comprising salmeterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
|
WO2018069210A1
(en)
|
2016-10-10 |
2018-04-19 |
Takeda Gmbh |
Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
|